Evidence map›Paper›PMID 42055333›Full record

ReviewThe Journal of biological chemistry2026

A coherent structural picture of the interaction of Tau with tubulin provides a link to its aggregation.

Benoît Gigant, Liza Ammar Khodja, Valérie Campanacci, Guy Lippens

Abstract readReview
In one paragraph

Review in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Benoît GigantUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France. Electronic address: benoit.gigant@i2bc.paris-saclay.fr.
Liza Ammar KhodjaUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.
Valérie CampanacciUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), Gif-sur-Yvette, France.
Guy LippensTBI, Université de Toulouse, CNRS, INRAE, INSA, Toulouse, France. Electronic address: glippens@insa-toulouse.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tauopathies are a group of neurodegenerative diseases characterized by the presence of insoluble filaments of the Tau protein in the brain. In physiological conditions, Tau is involved in the regulation of microtubule dynamics. The study of its interaction with different tubulin assemblies, using various experimental approaches, leads to a seemingly disparate picture. Here, we propose to integrate this information into a model of how Tau participates in microtubule assembly and stabilization. Related to its intrinsically disordered nature, the binding of Tau to microtubules involves both specific interactions, along protofilaments, and nonspecific ones, with the C-terminal region of tubulin subunits. In addition, the recent determination of a Tau:tubulin structure provides a model for a functional dimer of Tau targeting a microtubule aperture between protofilaments. Therefore, Tau regulates microtubule dynamics by modulating both longitudinal and lateral contacts. Finally, we discuss a possible connection of this dimer of Tau with its oligomerization, whether physiological or pathological.

Indexed as

tau ProteinsTubulinAnimalsHumansMicrotubulesProtein AggregatesProtein BindingProtein MultimerizationProtein Aggregatestau ProteinsTubulinAlzheimer's diseaseamyloidmicrotubulemicrotubule dynamics regulationstructural modeltauopathyTau protein (Tau)tubulin

Identifiers

PMID42055333
PMCPMC13224075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.